InsidersTradesSigma
Follow the 알테오젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 알테오젠 has published 2 public disclosures. Market capitalisation: €16,748.7bn. The latest transaction was disclosed on 7 April 2026 (Sale). Among the most active insiders: 박순재. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,996 of 29,064 companies
66.4
score / 100
Value40
Quality93
FCF yld0.5%
Earn yld0.8%
EV/EBITDA·
ROE25%
Gross mgn77%
Net mgn66%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
关于 알테오젠
Alteogen 是一家专注于医疗保健和制药领域的公司，在 XKRX 市场上市。它致力于创新生物制药的开发。